嵌合抗原受体
细胞毒性T细胞
细胞毒性
受体
生物
效应器
免疫学
抗原
免疫疗法
免疫系统
癌症研究
体外
遗传学
作者
Daniel B. Goodman,Camillia S. Azimi,Kendall Kearns,Kiavash Garakani,Julie M. Garcia,Nisarg Patel,Byungjin Hwang,David Lee,Emily Park,Chun Jimmie Ye,Alexander Marson,Jeff A. Bluestone,Kole T. Roybal
标识
DOI:10.1101/2021.07.11.451980
摘要
SUMMARY Chimeric antigen receptors (CARs) repurpose natural signaling components to retarget T cells to refractory cancers, but have shown limited efficacy against solid tumors. Here, we introduce ‘CAR Pooling’, a multiplexed approach to rapidly identify CAR designs with clinical potential. Forty CARs with diverse immune costimulatory domains were assessed in pooled assays for their ability to stimulate critical T cell effector functions during repetitive stimulation that mimics long-term tumor antigen exposure. Several non-native domains from the TNF receptor family exhibited enhanced proliferation (CD40) or cytotoxicity (BAFF-R and TACI) relative to clinical benchmarks, and fell into distinct states of memory, cytotoxicity, and metabolism. BAFF-R CAR T cells were enriched for a highly cytotoxic and NK-cell-like innate phenotype previously associated with positive clinical outcomes. ‘CAR Pooling’ enables efficient exploration of how CAR design affects cell activity and can be applied to optimize receptors across a range of applications and cell types.
科研通智能强力驱动
Strongly Powered by AbleSci AI